Pharmacological management of acute bronchiolitis

Melvin Wright, Charles J Mullett, Giovanni PiedimonteDepartment of Pediatrics, West Virginia University School of Medicine, Morgantown, WV, USAAbstract: This article reviews the current knowledge base related to the pharmacological treatments for acute bronchiolitis. Bronchiolitis is a common lower...

Full description

Bibliographic Details
Main Authors: Melvin Wright, Charles J Mullett, Giovanni Piedimonte
Format: Article
Language:English
Published: Dove Medical Press 2008-11-01
Series:Therapeutics and Clinical Risk Management
Online Access:http://www.dovepress.com/pharmacological-management-of-acute-bronchiolitis-a2545
Description
Summary:Melvin Wright, Charles J Mullett, Giovanni PiedimonteDepartment of Pediatrics, West Virginia University School of Medicine, Morgantown, WV, USAAbstract: This article reviews the current knowledge base related to the pharmacological treatments for acute bronchiolitis. Bronchiolitis is a common lower respiratory illness affecting infants worldwide. The mainstays of therapy include airway support, supplemental oxygen, and support of fluids and nutrition. Frequently tried pharmacological interventions, such as ribavirin, nebulized bronchodilators, and systemic corticosteroids, have not been proven to benefit patients with bronchiolitis. Antibiotics do not improve the clinical course of patients with bronchiolitis, and should be used only in those patients with proven concurrent bacterial infection. Exogenous surfactant and heliox therapy also cannot be recommended for routine use, but surfactant replacement holds promise and should be further studied.Keywords: bronchiolitis, respiratory syncytial virus, pharmacological, therapy, interventions
ISSN:1176-6336
1178-203X